Sunday 15 June 2014 |
|
13:00 – 15:00 |
Satellite Symposium (Merck & Co.) |
13:00 – 13:05 |
Welcome and Opening Remarks – O.A. Cornely (Germany) |
13:05 – 13:30 |
Pharmacologic Principles and Clinical Evidence for the Management of Mucormycosis – D. Kontoyiannis (USA) |
13:30 – 13:55 |
Therapeutic Drug Monitoring: Necessary for Prophylaxis? – D. Sheppard (Canada) |
13:55 – 14:20 |
Phase 1B Study of the Pharmacokinetics and Safety of Posaconazole Solid Oral Tablet in Patients at Risk for Invasive Fungal Infection (IFI) – R. Duarte (Spain) |
14:20 – 14:45 |
Phase 3 Study of the Pharmacokinetics and Safety of Posaconazole Solid Oral Tablet in Patients at Risk for Invasive Fungal Infection (IFI) – O. Cornely (Germany) |
14:45 – 14:55 |
Q&A – Faculty |
14:55 – 15:00 |
Closing Remarks – O. Cornely (Germany) |
16:30 – 18:30 |
Satellite Symposium organized by Pfizer Pharma |
Management of Infections in the Immunocompromised Patient Chair: G. Maschmeyer (Berlin) |
|
16:30 – 16:40 |
Welcome – G. Maschmeyer (Berlin) |
16:40 – 17:05 |
Management of Infections with Multiresistant Pathogens in the Immunocompromised Patient – M. Deja (Berlin) |
17:05 – 17:30 |
Azol Antifungals in High Risk Patients – C. Rieger (Munich) |
17:30 – 17:55 |
Impact of Latent Virus Infections on the Clinical Course of SOT-Patients – P. Reinke (Berlin) |
17:55 – 18:20 |
Vaccinations in Immunocompromised Patients – U. Baumann (Hannover) |
18:20 – 18:30 |
Discussion, Closing Remarks – G. Maschmeyer (Berlin) |
Monday 16 June 2014 |
|
12:30 – 14:00 |
Satellite Symposium organized by Astellas Pharma |
Clinical Problem Solving in Transplant Patients and Immunocompromised Hosts |
|
12:30 – 12:35 |
Introduction – J. M. Aguado (Madrid) |
12:35 – 13:00 |
Liver Transplantation in the MELD era – Infection Risks, Prophylaxis, Trends – L. Fischer (Hamburg) |
13:00 – 13:25 |
Clostridium difficile Infections (CDI) in Immunocompromised Patients – Minimizing Risks, Managing Consequences – O. Cornely (Koln) |
13:25 – 13:50 |
Antifungal Prophylaxis – Facing the Challenges and Obstacles – J. Maertens (Leuven) |
13:50 – 14:00 |
Wrap-up and Questions – J. M. Aguado (Madrid) |